Keyuan Pharmaceutical expects first-half 2026 net profit to rise 40.57% to 52.29% year-on-year

Earnings
โดย 每日经济新闻·Read original
Summary · why it matters

Keyuan Pharmaceutical issued an earnings forecast, expecting net profit attributable to shareholders of the listed company for the first half of 2026 to be between 60 million yuan and 65 million yuan, representing a year-on-year increase of 40.57% to 52.29%.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews